Contact Information: Contact: Robin John CFO 617-878-2135
Finny Kuruvilla, MD, PhD of Eventide Asset Management Named One of the Top Emerging Mutual Fund Managers
| Source: Eventide Asset Management
BOSTON, MA--(Marketwire - September 14, 2009) - Finny Kuruvilla, MD, PhD was named as one of the
top performing emerging mutual fund managers for new mutual funds that have
been in existence for less than 1.5 years according to Fund Mojo, a
financial network that provides financial intelligence, data collection and
analysis to financial advisors and investors. Selection criteria involved
analyzing fund managers who have outperformed category averages since their
inception.
Dr. Kuruvilla has managed the Eventide Gilead Fund (NASDAQ : ETGLX )
portfolio since its inception in July, 2008. He possesses a diverse
background in quantitative methods, with applications focused on
innovations in science, engineering, and medicine. He holds an MD from
Harvard Medical School, a PhD in Chemistry and Chemical Biology from
Harvard University, a master's degree in Electrical Engineering and
Computer Science from MIT, and a bachelor's degree from Caltech in
Chemistry. His residency and fellowship were completed at the Brigham &
Women's Hospital and Children's Hospital, Boston.
Dr. Kuruvilla is a managing partner with Eventide Asset Management, LLC.
Eventide Asset Management offers investment advisory services for both
individual and institutional investors and aims to invest in companies that
operate with integrity and create value for customer, shareholder, and
society. Eventide appeals to both the socially responsible and biblically
responsible investor.
Investment return and principal value will fluctuate with changing market
conditions so that when redeemed shares may be worth more or less than the
original costs. Please consider the investment objectives, risks, charges
and expenses carefully before investing. For a prospectus containing this
and other important information please download the prospectus from
http://www.eventidefunds.com or call the fund at 877.453.7877. Please read
the prospectus carefully before investing or sending money. Matrix Capital
Group, Inc., New York, NY distributor.